Isotopic Labeling of the Tyrosine Kinase Inhibitor Binimetinib with Fluorine-18 and Preclinical Evaluation
Journal of Medicinal Chemistry · 19.11.2026
DOI: 10.1021/acs.jmedchem.6c02001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.11.2026. Verfasst von Rémi Pelletier und 5 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Commissariat ? l'?nergie Atomique et aux ?nergies Alternatives.
Abstract (Originalsprache)
The Ras-Raf-MEK-ERK signaling pathway is involved in numerous cancers. Monitoring its overactivation by PET imaging remains challenging, yet it holds significant potential for personalized diagnostics. Here, we report the fluorine-18 isotopic radiolabeling of binimetinib, an FDA-approved specific allosteric MEK1/2 inhibitor, for the treatment of BRAF-positive melanoma. The inherent structure of binimetinib makes its radiolabeling a strong challenge, addressed by evaluating seven precursors using a simplified model compound. A fully automated, four-step, one-pot radiosynthesis afforded [18F]binimetinib with a 9 ± 5% radiochemical yield after 100 min with >95% radiochemical purity. In vitro evaluation of [18F]binimetinib demonstrated specific uptake in H358 cells with activated Ras-Raf-MEK-ERK. PET imaging of an H358 xenograft mouse model revealed promising tumor uptake at 4 h post-injection with 1.96 ± 0.51 % ID.cm−3 in the tumor. This study provides insight into the in vivo pharmacokinetic profile derived from PET imaging of [18F]binimetinib and its potential for investigating MEK target availability in tumors.
Förderung
- Commissariat ? l'?nergie Atomique et aux ?nergies Alternatives
Zitieren
APA
Pelletier, R., Truillet, C., Jego, B., Denis, C., Kuhnast, B., & Specklin, S. (2026). Isotopic Labeling of the Tyrosine Kinase Inhibitor Binimetinib with Fluorine-18 and Preclinical Evaluation. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02001
Vancouver
Pelletier R, Truillet C, Jego B, Denis C, Kuhnast B, Specklin S. Isotopic Labeling of the Tyrosine Kinase Inhibitor Binimetinib with Fluorine-18 and Preclinical Evaluation. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c02001
BibTeX
@article{Pelletier2026,
author = {Pelletier, Rémi and Truillet, Charles and Jego, Benoit and Denis, Caroline and Kuhnast, Bertrand and Specklin, Simon},
title = {Isotopic Labeling of the Tyrosine Kinase Inhibitor Binimetinib with Fluorine-18 and Preclinical Evaluation},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02001}
}
EUVIMED